Opening book details…
About this Medicine article
AVEREL: A Randomized Phase III Trial Evaluating Bevacizumab in Combination With Docetaxel and Trastuzumab As First-Line Therapy for HER2-Positive Locally Recurrent/Metastatic Breast Cancer by Gianni, Luca (author);Romieu, Gilles H. (author);Lichinitser, Michail (author);Serrano, Sergio V. (author);Mansutti, Mauro (author);Pivot, Xavier (author);Mariani, Paola (author);Andre, Fabrice (author);Chan, Arlene (author);Lipatov, Oleg (author);Chan, Stephen (author);Wardley, Andrew (author);Greil, Richard (author);Moore, Nicola (author);Prot, Sylvie (author);Pallaud, Celine (author);Semiglazov, Vladimir (author) is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Gianni, Luca (author);Romieu, Gilles H. (author);Lichinitser, Michail (author);Serrano, Sergio V. (author);Mansutti, Mauro (author);Pivot, Xavier (author);Mariani, Paola (author);Andre, Fabrice (author);Chan, Arlene (author);Lipatov, Oleg (author);Chan, Stephen (author);Wardley, Andrew (author);Greil, Richard (author);Moore, Nicola (author);Prot, Sylvie (author);Pallaud, Celine (author);Semiglazov, Vladimir (author)
- Publisher
- American Society of Clinical Oncology
- Published
- 2013
- Field
- Medicine (Health Sciences)